GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

MCY · Sep 30, 2025

MERCURY GENERAL CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000064996-25-000044Insurance
CashRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.cash

$1.3B · CORE · NOT_ENOUGH_HISTORY

Policy-benefit growth0thOwn-history percentile · N=11
Evidence method

Yoy · gp.insurance.policy_benefits

-3.89% · OPTIONAL · VALID

Net-income growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.net_income

21.46% · CORE · NOT_ENOUGH_HISTORY

Premium growth33thOwn-history percentile · N=12
Evidence method

Yoy · gp.insurance.premiums

6.80% · CORE · VALID

Revenue growth17thOwn-history percentile · N=12
Evidence method

Yoy · gp.fundamentals.revenue

3.56% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History9 statesHistory building
Period transition

What moved in the state?

Cash Increased
Previous
$1.1B
Current
$1.3B
Delta
$130.3M
Claims Growth Decreased
Previous
0.35%
Current
-3.89%
Delta
-4.24%
Earnings Growth Decreased
Previous
166.07%
Current
21.46%
Delta
-144.60%
Premium Growth Decreased
Previous
10.58%
Current
6.80%
Delta
-3.78%
Revenue Growth Decreased
Previous
13.25%
Current
3.56%
Delta
-9.68%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.